在社区和门诊环境中实践teclistamab管理的经验:血液学提供者的混合方法研究

Benjamin Derman1, Jane Jijun Liu2, Nicholas Bouchard3

  • 1University of Chicago Medical Center, Chicago, IL, USA.

PubMed
概括

门诊teclistamab逐步增加剂量 (SUD) 是可行的在社区实践为选定的患者. 这项研究详细介绍了成功的门诊teclistamab SUD的现实世界模型和实施因素.

相关概念视频

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
258
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
395